Stryker Corporation

Most Recent

  • uploads///Chart
    Earnings Report

    What Does Johnson & Johnson Predict for Its Medical Devices Segment?

    Johnson & Johnson’s (JNJ) medical devices segment deals with vision care, cardiovascular care, specialty surgery, orthopedics, surgical care, and diabetes care.

    By Mike Benson
  • uploads///revenue estimates
    Earnings Report

    Will Medtronic Maintain Its Revenue Growth Momentum in Fiscal 1Q18?

    In fiscal 1Q18, Wall Street analysts expect Medtronic’s (MDT) revenue to be ~$7.45 billion, which represents a rise of ~4% in comparison to its fiscal 1Q17 revenue of $7.17 billion.

    By Sarah Collins
  • uploads///REVENUE ESTIMATES
    Earnings Report

    Analysts Expect Medtronic’s Revenue to Rise 4% in Fiscal 4Q17

    Wall Street analysts expect Medtronic’s (MDT) revenue to be ~$7.9 billion in fiscal 4Q17, a rise of ~4% compared to its fiscal 4Q16 revenue of $7.6 billion.

    By Sarah Collins
  • uploads///STOCK PRICE
    Earnings Report

    How Has Medtronic’s Stock Performed Recently?

    Medtronic (MDT) was trading at $80.3 on November 15, 2016. It had a 50-day moving average of $83.7 and a 200-day moving average of $84.8.

    By Sarah Collins
  • uploads///revenue estimates
    Earnings Report

    Medtronic’s Revenue Is Estimated to Rise in Fiscal 2Q17

    On November 22, 2016, Medtronic (MDT) will announce its fiscal 2Q17 earnings for the period that ended on October 31, 2016.

    By Sarah Collins
  • uploads///aid __
    Company & Industry Overviews

    Boston Scientific Expands Its Endoscopy Business with EMcision Acquisition

    On March 5, 2018, Boston Scientific (BSX) announced the acquisition of EMcision, which will expand the company’s endoscopy business.

    By Sarah Collins
  • uploads///core strategies
    Company & Industry Overviews

    How Are Stryker’s Core Strategies Working Toward Its Growth?

    Stryker (SYK) registered strong 3Q16 earnings on October 27, 2016. The company’s reported earnings exceeded analysts’ estimates.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    BD’s Stock Price Performance after Recent 52-Week High

    On December 28, Becton, Dickinson and Company (BDX), or BD, closed trading on the day at $214.32 per share. Currently, BD stock’s 50-day moving average stands at $221.22.

    By Sarah Collins
  • uploads///eps estimates
    Earnings Report

    Will Medtronic Meet Analysts’ Earnings Estimates in Fiscal 1Q18?

    For the last several quarters, Medtronic has consistently exceeded analysts’ earnings estimates.

    By Sarah Collins
  • uploads///revenue estimates
    Company & Industry Overviews

    Stryker’s Recent Stock Price Movement: Upside Potential?

    Stryker stock has registered slightly volatile activity in the past few months. However, the stock largely remains on a bullish trajectory.

    By Sarah Collins
  • uploads///aerial view _
    Company & Industry Overviews

    Stryker Declines Buyout Talks with Boston Scientific

    On June 13, Stryker (SYK) said in a regulatory filing that it’s not in discussions with Boston Scientific related to its acquisition.

    By Sarah Collins
  • uploads///STOCK PRICE
    Earnings Report

    A Look at Medtronic’s Recent Stock Performance

    Medtronic (MDT) was trading at $83.9 on May 22, 2017. It had a 50-day moving average of $82.1 and a 200-day moving average of $78.4.

    By Sarah Collins
  • Healthcare

    Must-know: Key export barriers for medical device manufacturers

    Most large U.S. manufacturers have invested significant capital into emerging markets, including Medtronics, Johnson & Johnson, GE, and Stryker.

    By Amritpal Khalsa
  • uploads///analyst recommendations
    Company & Industry Overviews

    Wall Street Maintains ‘Strong Buy’ Recommendation for Stryker

    Analysts’ recommendations Stryker (SYK) has registered strong results over the last few quarters and has been expanding at a fast pace through organic and inorganic growth. The company has made a number of acquisitions and expanded its market presence across product lines and regions. Its most recent earnings results were reported on October 26, 2017. For details, read […]

    By Sarah Collins
  • uploads///key strategies
    Company & Industry Overviews

    Understanding Zimmer Biomet’s Latest Dividend Announcement

    On December 18, 2017, Zimmer Biomet Holdings (ZBH) announced a quarterly cash dividend of $0.24 per share for fiscal 4Q17.

    By Sarah Collins
  • uploads///eps estimates
    Earnings Report

    What Can We Expect for Stryker’s Earnings in 2Q16?

    In 1Q16, Stryker exceeded analysts’ EPS (earnings per share) estimate of $1.20, as well as the revenue estimate of ~$2.5 billion.

    By Sarah Collins
  • uploads///Align technolgies
    Company & Industry Overviews

    Align Technology Stock Recovers after Tanking Last Week

    Align Technology stock (ALGN) took a massive hit after Q2 earnings. So what was behind the massive decline, and what’s helping the stock recover?

    By Sushree Mohanty
  • uploads///core strategies
    Company & Industry Overviews

    How Stryker’s Margins Are Driven by Its CTG Program

    Cost transformation for growth (or CTG) is Stryker’s program that focuses on driving leveraged growth by structural cost optimization.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    What Are Stryker’s Key Growth Drivers in 2019?

    On its fourth-quarter earnings call, Stryker said that it expects its MedSurg segment to be a major growth driver for it in 2019.

    By Margaret Patrick
  • uploads///equipment _
    Company & Industry Overviews

    FDA Approves Zimmer Biomet’s ROSA, Stock Up 2.6%

    Today, Zimmer Biomet Holdings’ (ZBH) ROSA Knee System received FDA 510(k) clearance for robotically assisted total knee replacement surgeries.

    By Daniel Collins
  • uploads///MDT net income
    Company & Industry Overviews

    A Look at Medtronic’s Earnings Trends and Guidance for Fiscal 2019

    Medtronic (MDT) reported net income of $1.1 billion in the second quarter of fiscal 2019 compared to $2.0 billion in the second quarter of fiscal 2018.

    By Daniel Collins
  • uploads///BSX
    Company & Industry Overviews

    Why Analysts Are Mostly Positive on Boston Scientific Stock

    Boston Scientific stock rose from $24.79 at the close of market on December 29, 2017, to $34.80 at the close of market on November 23.

    By Daniel Collins
  • uploads///XRAY
    Company & Industry Overviews

    What Does Dentsply’s Bottom-Line Trend Indicate?

    Dentsply Sirona’s interest expense decreased marginally from $9.8 million in the third quarter of 2017 to $9.7 million in the third quarter.

    By Kenneth Smith
  • uploads///HOLX
    Company & Industry Overviews

    What Analysts Recommend for Hologic Stock

    In November 2018, of the total 20 analysts covering Hologic (HOLX), ten analysts have given the stock a “buy” or higher rating, and ten analysts have given it a “hold” rating.

    By Kenneth Smith
  • uploads///SYK
    Company & Industry Overviews

    Analysts Remain Bullish on Stryker Stock

    In November 2018, of the total 29 analysts covering Stryker (SYK), 19 analysts gave Stryker stock a “buy” or higher rating, and ten analysts have given it a “hold” rating.

    By Kenneth Smith
  • uploads///doctors office _
    Company & Industry Overviews

    How Stryker Is Positioned in November

    Stryker generated total revenues of $3.24 billion in the third quarter of 2018 as compared to $3.01 billion in the comparable period of 2017.

    By Kenneth Smith
  • uploads///molecule _
    Earnings Report

    How TransEnterix Has Been Performing in November

    In this series, we’ll explore TransEnterix’s financials, analyst recommendations, and valuation metrics.

    By Kenneth Smith
  • uploads///lab _
    Earnings Report

    Thermo Fisher Beats Analysts’ Estimates in Q3 2018 Earnings

    Thermo Fisher Scientific (TMO) reported its third-quarter results today. It surpassed analysts’ estimates for EPS and revenue.

    By Mike Benson
  • uploads///SYk ana reco
    Earnings Report

    What Analysts Recommend for Stryker Stock

    Of the total 28 analysts covering Stryker (SYK) in October 2018, 19 analysts have given the stock a “buy” or higher rating, and nine analysts have given Stryker a “hold” rating.

    By Kenneth Smith
  • uploads///Chart
    Earnings Report

    Thermo Fisher’s Third-Quarter Revenue Estimates

    The Life Sciences Solutions segment, including reagents, instruments, and consumables, contributes ~25% of Thermo Fisher’s total revenues.

    By Mike Benson
  • uploads///analysis _
    Earnings Report

    What to Expect from Thermo Fisher’s Third-Quarter Earnings

    Thermo Fisher Scientific (TMO), a leading life sciences company, is scheduled to release its third-quarter earnings on October 24.

    By Mike Benson
  • uploads///hospital _
    Earnings Report

    Zimmer Biomet Holdings: Revenue Trends ahead of Its Q3 Earnings

    Zimmer Biomet (ZBH) plans to release its Q3 earnings on October 26. Analysts expect ZBH to generate third-quarter revenues of $1.8 billion.

    By Daniel Collins
  • uploads///VAR FCF
    Earnings Report

    What to Expect from Varian’s Bottom Line in Q4 2018

    Varian Medical Systems (VAR) is expected to report net income of $105.05 million in the fourth quarter of fiscal 2018.

    By Kenneth Smith
  • uploads///ISRG RD
    Earnings Report

    How Intuitive’s Bottom Line Is Expected to Look in Q3 2018

    Intuitive Surgical’s (ISRG) cost of goods sold is expected to rise 16.82% to $265.76 million in the third quarter of 2018.

    By Kenneth Smith
  • uploads///RMD ana reco
    Company & Industry Overviews

    What ResMed’s Valuation Trend Indicates

    The mean rating for ResMed (RMD) stock is 2.6, and its target price is $104.69.

    By Kenneth Smith
  • uploads///A ana reco
    Company & Industry Overviews

    What’s the Upside Potential for Agilent Technologies Stock?

    In the last three months, Agilent Technologies (A) stock has risen from $61.14 on June 27, 2018, to $70.33 in September 2018.

    By Kenneth Smith
  • uploads///WAT ana reco
    Company & Industry Overviews

    What Waters Corporation’s Valuation Trend Indicates

    In September, of the 15 analysts covering Waters Corporation (WAT) stock, ten have given it “holds.”

    By Kenneth Smith
  • uploads///Chart
    Company & Industry Overviews

    Thermo Fisher to Offer Complete Cannabis Testing Solutions

    Thermo Fisher Scientific (TMO) announced on September 7, 2018, that the company offers end-to-end analytical solutions that comply with cannabis testing standards as defined by Health Canada.

    By Mike Benson
  • uploads///Chart
    Company & Industry Overviews

    What Analysts Expect for Abiomed

    Wall Street analysts estimate Abiomed (ABMD) will report 29.9% growth in revenues to ~$771.0 million in 2019 as compared to $593.7 million in 2018.

    By Mike Benson
  • uploads///VAR
    Company & Industry Overviews

    Here’s What Varian Medical Systems’ Valuation Trend Indicates

    Of the nine analysts covering Varian Medical Systems (VAR) stock, three have given it a “strong buy,” three have given it a “hold,” and three have given it a “sell.”

    By Kenneth Smith
  • uploads///mammography _
    Company & Industry Overviews

    Analysts’ Recommendations for Hologic and Its Peers in August

    Of the 19 analysts covering Hologic (HOLX) in August, five rated it as a “strong buy,” and seven rated it as a “buy.”

    By Margaret Patrick
  • uploads///EDIT
    Earnings Report

    Why Editas Medicine Stock Fell in July

    Editas Medicine’s (EDIT) general and administrative expenses are expected to rise 39.57% year-over-year in the second quarter.

    By Kenneth Smith
  • uploads///Graph
    Company & Industry Overviews

    Commercial Launch of NexSys PCS May Boost Haemonetics’s Revenues

    Haemonetics is also involved in plasma donor center experience programs that involve the use of NexSys PCS device and YES technology.

    By Margaret Patrick
  • uploads///recommendations
    Company & Industry Overviews

    Wall Street’s Recommendations and Target Prices for BSX

    Analysts’ recommendations on Boston Scientific Boston Scientific (BSX) is a leading medical technology company in the United States. The company has been a leading player in minimally invasive therapies for a range of cardiovascular and rhythm management diseases, a space that has become increasingly competitive over the years. Boston Scientific has been expanding in other areas, including endoscopy under its MedSurg […]

    By Sarah Collins
  • uploads///medtech growth comparison
    Company & Industry Overviews

    Where Is SYK Stock Headed after Its Recent All-Time Highs?

    On February 26, 2018, Stryker (SYK) closed trading at $165.77. The stock was trading at its all-time high of $170 on January 29, 2018.

    By Sarah Collins
  • uploads///ITGR geographic segments
    Company & Industry Overviews

    The Geographic Segments of Integer Holdings Corporation

    Integer Holdings Corporation provides custom battery packs to energy, military, and environmental markets for use in extreme environments.

    By Kenneth Smith
  • uploads///recommendations
    Earnings Report

    What Analysts Recommend for Medtronic ahead of 3Q18 Earnings

    Medtronic (MDT) plans to release its 3Q18 earnings results on February 20, 2018.

    By Sarah Collins
  • uploads///Q_highlights
    Company & Industry Overviews

    Inside Abbott Laboratories’ 4Q17 Earnings Results: Key Highlights

    Abbott Laboratories (ABT) reported sales of $7.6 billion and adjusted diluted EPS (earnings per share) of $0.74 for fiscal 4Q17.

    By Sarah Collins
  • uploads///EPS ESTIMATES
    Earnings Report

    ZBH’s 4Q17 Earnings Results Meet Analysts’ Estimates

    Zimmer Biomet Holdings announced its 4Q17 and 2017 results on January 30. The company’s sales exceeded analysts’ estimates, while its adjusted earnings per share managed to meet estimates.

    By Sarah Collins
  • uploads///guidance
    Company & Industry Overviews

    A Look at Johnson & Johnson’s 2018 Guidance

    Johnson & Johnson (JNJ) provided 2018 guidance during the company’s earnings results release on January 23, 2018.

    By Sarah Collins
  • uploads///EARNINGS ESTIMATES
    Earnings Report

    Will ZBH Beat Wall Street Earnings Estimates in 4Q17?

    Zimmer Biomet Holdings (ZBH) accounts for ~0.17% of the total holdings of the Vanguard International High Dividend Yield ETF (VYMI). Zimmer Biomet Holdings plans to announce its 4Q17 and fiscal 2017 earnings results on January 30.

    By Sarah Collins
  • uploads///stock price
    Company & Industry Overviews

    Stryker’s Stock Rally Continues with 52-Week High Yesterday

    On January 9, Stryker (SYK) traded at a 52-week high of $164.2 per share. The stock ended trading with a closing price of $160.4.

    By Sarah Collins
  • uploads///q guidance
    Company & Industry Overviews

    Baxter International Expected to Post Strong 4Q17 Results

    Earnings results Baxter International (BAX) is expected to announce its 4Q17 and fiscal 2017 earnings results on or around January 30, 2018. The company announced stellar 3Q17 earnings results on October 25, 2017. Year-over-year, Baxter International expects to report 4Q17 sales growth of 4%–5% and constant-currency sales growth of ~2%. However, the company’s operational sales growth, expected […]

    By Sarah Collins
  • uploads///harpoon
    Company & Industry Overviews

    Edwards Lifesciences Expands Portfolio with Harpoon Medical Acquisition

    On December 6, 2017, Edwards Lifesciences (EW) announced the completion of its acquisition of Harpoon Medical for $100 million in cash on December 1, 2017.

    By Sarah Collins
  • uploads///product segments
    Company & Industry Overviews

    TMO’s Acquisition from EPTEK Technology Could Boost Its China Opportunity

    On December 4, 2017, Thermo Fisher Scientific (TMO) completed the acquisition of some assets from EPTEK Technology and related entities that have offices in mainland China and Taiwan.

    By Sarah Collins
  • uploads///acquisitions
    Company & Industry Overviews

    Stryker’s Inorganic Growth Strategy Continues to Boost Growth

    Stryker’s acquisition-driven growth strategy Stryker (SYK) has been growing at a fast pace through inorganic growth. It has undertaken a number of strategic acquisitions recently. In 3Q17, acquisitions contributed approximately 0.6% of the company’s YoY (year-over-year) sales growth, and in the first three quarters of 2017, Stryker acquisitions contributed ~3.2% of the company’s sales growth […]

    By Sarah Collins
  • uploads///neuroform atlas
    Company & Industry Overviews

    Stryker’s FDA Approval Accelerates Neck Aneurysm Treatments

    On November 9, 2017, Stryker (SYK) announced FDA approval for the Neuroform Atlas Stent System, which is approved for marketing under an HDE.

    By Sarah Collins
  • uploads///FREE CASH FLOWS
    Company & Industry Overviews

    The Free Cash Flow Estimates of Medtronic in 2018 and Beyond

    In fiscal 2Q18, Medtronic used a portion of its divestiture proceeds toward stock buybacks. The total share repurchases in the quarter came in at ~$568.0 million.

    By Sarah Collins
  • uploads///medical device segment performance
    Company & Industry Overviews

    How JNJ’s Medical Devices Business Restructuring Efforts Are Panning Out

    In 3Q17, Johnson & Johnson (JNJ) reported ~$19.7 billion in sales. The company’s Medical Devices business generated ~33.5% of the total sales.

    By Sarah Collins
  • uploads///OPERATIONAL PLANS
    Company & Industry Overviews

    Zimmer Biomet’s Plan to Revive Growth amid Supply Disruptions

    Zimmer Biomet Holdings has laid down a dual sourcing strategy to resolve production issues at its Warsaw facility.

    By Sarah Collins
  • uploads///GLOBAL FOOTPRINTS
    Company & Industry Overviews

    Asia-Pacific Still Zimmer Biomet’s Strongest Geography

    Zimmer Biomet Holdings witnessed a strong performance in its Asia-Pacific region. It contributed 16% to the company’s total sales.

    By Sarah Collins
  • uploads///mako
    Earnings Report

    How Mako Robots Are Driving Stryker’s Sales in 2017

    Mako sales in 3Q17 In 3Q17, Stryker sold 33 Mako robots, compared with 30 robots in 3Q16. In 2Q17, Stryker installed 26 Mako robots. Of these 33 robots, 23 were installed in the United States. Around 40% of US sales are expected to be in competitive accounts. Stryker is training surgeons on its total knee application […]

    By Sarah Collins
  • uploads///da vinci x
    Company & Industry Overviews

    How Intuitive Surgical Is Expanding Its Da Vinci X Systems Worldwide

    Intuitive Surgical’s (ISRG) Da Vinci X received early FDA approval in May 2017 and was given a CE Mark in Europe in April 2017.

    By Sarah Collins
  • uploads///Chart  ABT
    Healthcare

    Abbott Laboratories Stock: Performance in 3Q17

    Abbott Laboratories stock has risen ~9.7% in 3Q17. It has risen 45.8% year-to-date as of October 20, 2017.

    By Mike Benson
  • uploads///medical device segment growth strategy
    Earnings Report

    J&J Completed the Divestiture of Its Neurosurgery Business

    Johnson & Johnson’s (JNJ) medical device business has been restructuring in order to focus on higher growth areas with potential expansion opportunities.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Understanding BD’s Recent Stock Performance

    BD has a 50-day moving average of $197.25, while its 200-day moving average is $192.35.

    By Sarah Collins
  • uploads///faster growth markets
    Company & Industry Overviews

    How Boston Scientific Plans to Expand in High-Growth Markets

    Boston Scientific is focused on accelerating the company’s growth by expanding across high-growth markets outside the United States.

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    Why Most Analysts Recommend a ‘Buy’ on ZBH Stock

    ZBH stock’s consensus 12-month target price is $135.6, which amounts to about a 17.5% return potential over its price of $115.5 on September 19, 2017.

    By Sarah Collins
  • uploads///knee market share
    Company & Industry Overviews

    ZBH’s Persona Partial Knee Launch Expands Knee Implant Portfolio

    On September 11, 2017, Zimmer Biomet Holdings (ZBH) announced the launch of its Persona Partial Knee System.

    By Sarah Collins
  • uploads///margin
    Company & Industry Overviews

    Boston Scientific’s Updated 2017 Guidance

    Boston Scientific (BSX) expects to register 2017 revenues of $8.9 billion–$9.0 billion compared to its previous guidance of $8.8 billion–$8.9 billion.

    By Sarah Collins
  • uploads///STRATEGY
    Company & Industry Overviews

    Boston Scientific’s Expansion Plans in a Fast-Growing Market

    Boston Scientific (BSX) has been shifting its focus away from low-growth markets and is trying to enter the high-growth adjacent markets.

    By Sarah Collins
  • uploads///pipeline
    Company & Industry Overviews

    Medtronic’s Robust Product Pipeline

    On May 1, 2017, Medtronic announced the FDA approval of its Resolute Onyx DES (drug eluting stent) for adult patients suffering from coronary artery disease.

    By Sarah Collins
  • uploads///margin
    Company & Industry Overviews

    What’s behind Medtronic’s Accelerating Margin Expansion?

    In fiscal 1Q18, Medtronic (MDT) reported ~26.9% of operating margin on a constant currency basis. This represented year-over-year growth of ~50 basis points.

    By Sarah Collins
  • uploads///STOCK PRICE
    Company & Industry Overviews

    Taking a Look at Stryker’s Recent Stock Price Performance

    On August 31, Stryker (SYK) closed trading at a closing price of $139.3. It has a 50-day moving average of $144.7 and a 200-day moving average of $137.5.

    By Sarah Collins
  • uploads///EMERGING MARKET OPORTUNITY
    Company & Industry Overviews

    Medtronic’s Emerging Market Position and Opportunities for Fiscal 2018

    Medtronic (MDT) registered revenues of ~$1.0 billion revenues from emerging markets in fiscal 1Q18, which represents YoY (year-over-year) sales growth of ~11% in that market.

    By Sarah Collins
  • uploads///sage
    Company & Industry Overviews

    Stryker Stock Falls Due to the Impact of the Sage Products Recall

    On August 23, Stryker (SYK) announced a voluntary product recall of specific lots of oral care products that form part of the company’s Sage business unit.

    By Sarah Collins
  • uploads///services ecoomic value
    Company & Industry Overviews

    How Medtronic Is Accelerating Its Economic Value Growth Strategy

    Medtronic’s (MDT) Hospital Solutions segment registered double-digit growth in fiscal 1Q18.

    By Sarah Collins
  • uploads///EMERGING MARKET PERFORMANCE
    Company & Industry Overviews

    How Is Becton Dickinson Progressing with Emerging Market Growth?

    Becton Dickinson’s (BDX) emerging markets registered a strong double-digit growth of 10.9% in 3Q17.

    By Sarah Collins
  • uploads///PROJECTIONS
    Earnings Report

    What Investors Can Expect from Medtronic’s Fiscal 1Q18 Results

    In fiscal 4Q17, Medtronic’s revenue came in at $7.9 billion, representing YoY (year-over-year) growth of ~5%.

    By Sarah Collins
  • uploads///PROTON THERAPY
    Company & Industry Overviews

    How Varian Is Harnessing Proton Therapy Market Opportunities

    Proton therapy market opportunities The proton therapy market is a highly lucrative opportunity area for Varian Medical Systems (VAR). Proton therapy uses protons for treating cancer instead of X-rays. According to a Medgadget report, the global proton therapy market is expected to double by the year 2022. Though the United States has the biggest proton […]

    By Sarah Collins
  • uploads///STOCK
    Earnings Report

    Key Drivers behind BDX’s Recent Stock Performance

    BDX has a 50-day moving average of $196.80 and a 200-day moving average of $185.70.

    By Sarah Collins
  • uploads///stock price
    Earnings Report

    How Thermo Fisher Scientific’s Stock Has Performed

    Thermo Fisher Scientific (TMO) closed trading at $175.3 on July 27, 2017.

    By Sarah Collins
  • uploads///revenue estimates
    Earnings Report

    Stryker Exceeded Analysts’ Sales Estimates in 2Q17

    On July 27, 2017, Stryker (SYK) released its 2Q17 earnings. The company reported strong earnings and exceeded analysts’ expectations.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    Understanding Abiomed’s Changing Payment Structure Plans for Impella

    Abiomed (ABMD) reported a ~100% reorder rate in fiscal 4Q17, amounting to around $103.3 million, which was 34% higher on a YoY basis.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Where Abiomed Plans to Expand Impella CP’s Label

    About 40% of patients succumb to heart failure within five years. Abiomed believes that it is reperfusion injuries that cause these problems.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Why Abiomed Expects to Benefit from Impella in Cardiogenic Shock

    On March 23, 2015, the FDA approved Abiomed’s Impella 2.5 heart pump as a temporary ventricular support device.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Behind Abiomed’s Plans to Create a Greater Awareness of Impella

    To target patients across communities, Abiomed (ABMD) has been developing a hub-and-spoke model with hospitals.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    Abiomed Aims to Expand Impella RP’s Penetration Going Forward

    In March 2017, Abiomed (ABMD) submitted premarket approval (or PMA) to the FDA for its Impella RP device far ahead of schedule.

    By Margaret Patrick
  • uploads///MED DEVICE REVENUES
    Earnings Report

    Behind the Major Drivers of JNJ’s Medical Device Growth

    Johnson & Johnson (JNJ) reported Medical Devices segment sales of ~$6.7 billion in 2Q17, compared with $6.4 billion in 2Q16.

    By Sarah Collins
  • uploads///GE Additive Manufacturing
    Company & Industry Overviews

    Stryker’s Partnership with GE: Growth in Additive Manufacturing

    In June 2017, Stryker (SYK) entered into a partnership with General Electric (GE) to expand its additive manufacturing business.

    By Sarah Collins
  • uploads///revenues by segment
    Company & Industry Overviews

    Stryker Expands Its Interventional Spine Segment

    On July 11, 2017, Stryker announced that it received the FDA 510(k) clearance for its MultiGen 2 RF (radio frequency) generator.

    By Sarah Collins
  • uploads///eps estimates
    Earnings Report

    What to Expect from Intuitive Surgical’s 2Q17 Earnings

    Analysts estimate that Intuitive Surgical will post 2Q17 EPS (earnings per share) of ~$4.76. In 1Q17, Intuitive Surgical exceeded analysts’ diluted EPS estimate of $4.67.

    By Sarah Collins
  • uploads///STOCK
    Company & Industry Overviews

    Behind BD’s Recent New Stock Price High

    BD (BDX) closed trading at $195.3 on July 6, 2017, ahead of its 50-day moving average of $191.3 and its 200-day moving average of $181.9.

    By Sarah Collins
  • uploads///Chart  ABT
    Miscellaneous

    A Look at Abbott Laboratories Stock for 2Q17

    Wall Street analysts estimate that Abbott Laboratories (ABT) stock has the potential to return ~6.1% over the next 12 months.

    By Mike Benson
  • uploads///segment wise revenues
    Company & Industry Overviews

    Inside JNJ’s Inorganic Strategy in Medical Devices: The Latest Acquisitions

    In February 2017, JNJ completed its acquisition of Abbott Medical Optics, and the parent company’s 1Q17 results included ~$124 million of Abbott Medical Optics’ sales.

    By Sarah Collins
  • uploads///knee market share
    Company & Industry Overviews

    Zimmer Biomet Expands Portfolio with X-Ray–Based Knee System

    On June 28, 2017, Zimmer Biomet announced the launch of its X-PSI Knee System, an X-ray–based surgical system that allows patient-specific implant positioning.

    By Sarah Collins
  • uploads///geographic segmentationn
    Company & Industry Overviews

    How Stryker Plans to Capture the International Markets

    Most of Stryker’s emerging market sales are from China. However, Europe and emerging markets sales have witnessed high growth in recent quarters.

    By Sarah Collins
  • uploads///mako sales
    Company & Industry Overviews

    Stryker’s Plan to Strengthen Position in Robotics Market Space

    At the end of 1Q17, Stryker had placed 350 robots in the United States and completed about 1,400 MAKO total knee replacements.

    By Sarah Collins
  • uploads///tyrx
    Company & Industry Overviews

    Medtronic’s Agreement Will Expand the Use of Its Tyrx Envelopes

    Medtronic’s (MDT) Tyrx envelope is an antibacterial and fully-absorbable device that helps prevent surgical site infections.

    By Sarah Collins
  • uploads///dbs
    Company & Industry Overviews

    Medtronic Received Health Canada License for SureTune3

    On June 6, 2017, Medtronic (MDT) received the Health Canada license for its SureTune3 software for DBS (deep brain stimulation) therapy.

    By Sarah Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.